Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
AIDS and Behavior
Published in: AIDS and Behavior 3/2001

01-09-2001

Initial Development of Scales to Assess Self-Efficacy for Disclosing HIV Status and Negotiating Safer Sex in HIV-Positive Persons

Authors: Seth C. Kalichman, David Rompa, Kari DiFonzo, Dolores Simpson, Florence Kyomugisha, James Austin, Webster Luke

Published in: AIDS and Behavior | Issue 3/2001

Login to get access
Metadata
Title
Initial Development of Scales to Assess Self-Efficacy for Disclosing HIV Status and Negotiating Safer Sex in HIV-Positive Persons
Authors
Seth C. Kalichman
David Rompa
Kari DiFonzo
Dolores Simpson
Florence Kyomugisha
James Austin
Webster Luke
Publication date
01-09-2001
Publisher
Kluwer Academic Publishers-Plenum Publishers
Published in
AIDS and Behavior / Issue 3/2001
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1023/A:1011300912395

Other articles of this Issue 3/2001

AIDS and Behavior 3/2001 Go to the issue

OriginalPaper

Predictors of High-Risk Sexual Behavior Among People Living With HIV/AIDS

OriginalPaper

Attributions About One's HIV Infection and Unsafe Sex in Seropositive Men Who Have Sex With Men

OriginalPaper

A Telephone Based Brief Intervention Using Motivational Enhancement to Facilitate HIV Risk Reduction Among MSM: A Pilot Study

OriginalPaper

The Psychosocial Functioning of HIV+ and HIV− African American Recent Mothers

OriginalPaper

A Lifetime Alcohol or Other Drug Use Disorder and Specific Psychiatric Symptoms Predict Sexual Risk for HIV Infection Among People With Severe Mental Illness

OriginalPaper

Longitudinal Study of Condom Use Patterns Among Women With or at Risk for HIV
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits